| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.03 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.065 | 0.04 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |